secwatch / observer
8-K filed November 15, 2024, 6:59 PM ET CIK 0001267813
leadership confidence high sentiment negative materiality 0.60

Three directors resign from Marinus board; board size reduced to six

MARINUS PHARMACEUTICALS, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sarah Noonberg

Director
MARINUS PHARMACEUTICALS, INC.
Effective
2024-11-14
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
Departed

Charles Austin

Director
MARINUS PHARMACEUTICALS, INC.
Effective
2024-11-14
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
Departed

Saraswathy V. Nochur

Director
MARINUS PHARMACEUTICALS, INC.
Effective
2024-11-14
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sarah Noonberg resigned as Director at MARINUS PHARMACEUTICALS, INC..

Action
resigned
Role
Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Charles Austin resigned as Director at MARINUS PHARMACEUTICALS, INC..

Action
resigned
Role
Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Saraswathy V. Nochur resigned as Director at MARINUS PHARMACEUTICALS, INC..

Action
resigned
Role
Director
Exact text from the filing
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001558370-24-015780
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.